Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,179
archived clinical trials in
Anxiety

Evaluating Parenting Styles and Child Temperament Associated With Child Anxiety Disorders
Child Anxiety Disorders: Parenting and Temperament Effects
Status: Enrolling
Updated:  3/10/2016
Pediatric Anxiety Research Center/Bradley Hospital/Brown Medical School
619
mi
from 43215
Providence, RI
Evaluating Parenting Styles and Child Temperament Associated With Child Anxiety Disorders
Child Anxiety Disorders: Parenting and Temperament Effects
Status: Enrolling
Updated: 3/10/2016
Pediatric Anxiety Research Center/Bradley Hospital/Brown Medical School
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Birmingham Psychiatry Pharaceutical Studies, Inc.
499
mi
from 43215
Birmingham, AL
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Birmingham Psychiatry Pharaceutical Studies, Inc.
499
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
1960
mi
from 43215
Arcadia, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
1960
mi
from 43215
Arcadia, CA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Southwestern Research
1979
mi
from 43215
Beverly Hills, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Southwestern Research
1979
mi
from 43215
Beverly Hills, CA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Southwestern Research, Inc.
1972
mi
from 43215
Burbank, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Southwestern Research, Inc.
1972
mi
from 43215
Burbank, CA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
California Clinical Trials Medical Group
1967
mi
from 43215
Glendale, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
California Clinical Trials Medical Group
1967
mi
from 43215
Glendale, CA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
1963
mi
from 43215
Newport Beach, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
1963
mi
from 43215
Newport Beach, CA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Excell Research, Inc.
1944
mi
from 43215
Oceanside, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Excell Research, Inc.
1944
mi
from 43215
Oceanside, CA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
California Clinical Trials Medical Group
1971
mi
from 43215
Paramount, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
California Clinical Trials Medical Group
1971
mi
from 43215
Paramount, CA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Southwestern Research, Inc.
1964
mi
from 43215
Pasadena, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Southwestern Research, Inc.
1964
mi
from 43215
Pasadena, CA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
California Clinical Trials Medical Group, Inc.
1947
mi
from 43215
San Diego, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
California Clinical Trials Medical Group, Inc.
1947
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Stanford Universtiy Medical center
2101
mi
from 43215
Stanford, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Stanford Universtiy Medical center
2101
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
University of CT Health Center
545
mi
from 43215
Farmington, CT
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
University of CT Health Center
545
mi
from 43215
Farmington, CT
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Comprehensive Psychiatric Care
582
mi
from 43215
Norwich, CT
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Comprehensive Psychiatric Care
582
mi
from 43215
Norwich, CT
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Florida Clinical Research Center, LLC
862
mi
from 43215
Bradenton, FL
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Florida Clinical Research Center, LLC
862
mi
from 43215
Bradenton, FL
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Sarkis Clinical Trials
713
mi
from 43215
Gainsville, FL
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Sarkis Clinical Trials
713
mi
from 43215
Gainsville, FL
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Clinical Neuroscience Solutions, Inc.
673
mi
from 43215
Jacksonville, FL
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Clinical Neuroscience Solutions, Inc.
673
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Clinical Neuroscience Solutions, Inc
796
mi
from 43215
Orlando, FL
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Clinical Neuroscience Solutions, Inc
796
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Comprehensive NeuroScience, Inc.
835
mi
from 43215
St. Petersburg, FL
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Comprehensive NeuroScience, Inc.
835
mi
from 43215
St. Petersburg, FL
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Stedman Clinical Trials
821
mi
from 43215
Tampa, FL
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Stedman Clinical Trials
821
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Janus Center for Psychiatric Research
927
mi
from 43215
West Palm Beach, FL
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Janus Center for Psychiatric Research
927
mi
from 43215
West Palm Beach, FL
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Comprehensive NeuroScience, Inc.
423
mi
from 43215
Atlanta, GA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Comprehensive NeuroScience, Inc.
423
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Carmen Research
427
mi
from 43215
Smyrna, GA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Carmen Research
427
mi
from 43215
Smyrna, GA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Alexian Brothers Center for Psychiatric Research
302
mi
from 43215
Hoffman Estates, IL
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Alexian Brothers Center for Psychiatric Research
302
mi
from 43215
Hoffman Estates, IL
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Comprehensive NeuroScience, Inc.
288
mi
from 43215
Park Ridge, IL
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Comprehensive NeuroScience, Inc.
288
mi
from 43215
Park Ridge, IL
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Vince and Associats Clinical Research
624
mi
from 43215
Overland Park, KA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Vince and Associats Clinical Research
624
mi
from 43215
Overland Park, KA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Clinical Trials Technology, Inc
622
mi
from 43215
Prairie Village, KA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Clinical Trials Technology, Inc
622
mi
from 43215
Prairie Village, KA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Pedia Research LLC
270
mi
from 43215
Owensboro, KY
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Pedia Research LLC
270
mi
from 43215
Owensboro, KY
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Pharasite Research, Inc.
336
mi
from 43215
Baltimore, MD
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Pharasite Research, Inc.
336
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Coastal Research Associates, Inc.
644
mi
from 43215
Braintree, MA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Coastal Research Associates, Inc.
644
mi
from 43215
Braintree, MA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Center For Emotional Fitness
424
mi
from 43215
Cherry Hill, NJ
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Center For Emotional Fitness
424
mi
from 43215
Cherry Hill, NJ
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
CRI Worldwide, LLC
426
mi
from 43215
Clementon, NJ
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
CRI Worldwide, LLC
426
mi
from 43215
Clementon, NJ
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Social Psychiatry Research Institute
479
mi
from 43215
Brooklyn, NY
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Social Psychiatry Research Institute
479
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Neurobehavioral Research, Inc.
491
mi
from 43215
Cedarhurst, NY
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Neurobehavioral Research, Inc.
491
mi
from 43215
Cedarhurst, NY
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Comprehensive Neuroscience
488
mi
from 43215
Fresh Meadows, NY
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Comprehensive Neuroscience
488
mi
from 43215
Fresh Meadows, NY
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Fieve Clinica Services, Inc.
480
mi
from 43215
New York, NY
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Fieve Clinica Services, Inc.
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Medical & Behavioral Health Research
478
mi
from 43215
New York, NY
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Medical & Behavioral Health Research
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Richmond Behavioral Associates
468
mi
from 43215
Staten Island, NY
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Richmond Behavioral Associates
468
mi
from 43215
Staten Island, NY
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Glenwood Psychiatric Associates, P.L.L.C.
372
mi
from 43215
Raleigh, NC
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Glenwood Psychiatric Associates, P.L.L.C.
372
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Horizon Medical Services
1006
mi
from 43215
Bismarck, ND
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Horizon Medical Services
1006
mi
from 43215
Bismarck, ND
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
North Coast Clinical Trials, Inc.
130
mi
from 43215
Beachwood, OH
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
North Coast Clinical Trials, Inc.
130
mi
from 43215
Beachwood, OH
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Patient Priority Clinical Sties, LLC
87
mi
from 43215
Cincinnati, OH
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Patient Priority Clinical Sties, LLC
87
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Midwest Clinical Research Center
65
mi
from 43215
Dayton, OH
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Midwest Clinical Research Center
65
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
North Star Mdical Research, LLC
115
mi
from 43215
Middleburg Heights, OH
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
North Star Mdical Research, LLC
115
mi
from 43215
Middleburg Heights, OH
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
IPS Research Company
849
mi
from 43215
Oklahoma City, OK
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
IPS Research Company
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Oregon Center for Clinical Investigations, Inc.
2055
mi
from 43215
Eugene, OR
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Oregon Center for Clinical Investigations, Inc.
2055
mi
from 43215
Eugene, OR
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Oregon Center for Clinical Investigations, Inc
2045
mi
from 43215
Salem, OR
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Oregon Center for Clinical Investigations, Inc
2045
mi
from 43215
Salem, OR
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
CRI Worldwide, LLC
412
mi
from 43215
Philadelphia, PA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
CRI Worldwide, LLC
412
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Rhode Island Mood & Memory Research Institute
621
mi
from 43215
East Providence, RI
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Rhode Island Mood & Memory Research Institute
621
mi
from 43215
East Providence, RI
Click here to add this to my saved trials